Study of Tranexamic Acid to Reduce Bleeding and Swelling During and After Rhinoplasty Surgery
Led by Vanderbilt University Medical Center · Updated on 2026-05-07
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of tranexamic acid TXA on bleeding, swelling, and bruising in patients undergoing rhinoplasty surgery. This prospective randomized study involves patients treated by two facial plastic surgeons at Vanderbilt University Medical Center. The study aims to understand how TXA may influence intraoperative and postoperative outcomes such as bleeding during surgery and swelling and bruising afterward.
Participants will be randomly assigned to receive either 1 gram of intravenous TXA in the operating room before surgery or routine care without TXA. The treatment is administered just prior to the surgical incision, alongside the usual preoperative antibiotics. The study anticipates enrolling between 60 and 100 patients, comparing those given TXA versus those who are not, to assess differences in bleeding and postoperative symptoms.
During the study, participants will be monitored for bleeding through surgical sponge weight and suction canister volume during the operation. Postoperative assessments include patient ratings of bleeding using a visual scale, as well as evaluations of swelling and bruising up to one week after surgery. Researchers will also track any medical interventions needed to control bleeding, ensuring comprehensive safety monitoring throughout the perioperative period.
CONDITIONS
Brief Title
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis
Research Team
S
Shiayin F Yang, MD
J
Jaclyn Lee, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Tranexamic Acid Given Intravenously
Standard Care – No Tranexamic Acid
What it is
A single intravenous dose of tranexamic acid (1 gram) given before rhinoplasty surgery to reduce bleeding.
No tranexamic acid is administered. Patients receive standard care without antifibrinolytic medication before their rhinoplasty.
Role in trial
Investigational arm to assess whether intravenous tranexamic acid reduces bleeding, edema, or bruising in rhinoplasty.
Serves as the comparison group to evaluate outcomes with standard care in the absence of tranexamic acid.
Primary use
Investigated for prevention of intraoperative and postoperative bleeding, and reduction of swelling and bruising after rhinoplasty.
Standard care for rhinoplasty, used to observe outcomes without antifibrinolytic treatment.
How it is given or performed
Tranexamic acid is administered as a 1 gram intravenous infusion in the operating room approximately 10 minutes before starting rhinoplasty.
No additional medication or placebo is administered before surgery for this group.
Evidence status
Multiple randomized trials and systematic reviews have shown that tranexamic acid used in rhinoplasty can reduce intraoperative and postoperative blood loss, and may also decrease swelling and bruising.
Standard rhinoplasty without tranexamic acid does not actively prevent bleeding with an antifibrinolytic. Published studies show higher rates of intraoperative bleeding, swelling, and bruising compared to tranexamic acid groups.
Important limitations
Although tranexamic acid has shown benefit, data on rare risks such as thromboembolism in aesthetic surgery are limited, and optimal dosing for rhinoplasty patients is still being investigated.
As standard care does not use an antifibrinolytic, perioperative bleeding and postoperative bruising or swelling may be greater compared to groups given tranexamic acid.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Adults at least 18 years of age who elect to undergo cosmetic or functional open primary rhinoplasty with osteotomies by Drs. Yang or Patel at Vanderbilt University Medical Center
No other facial plastic procedures or sinus surgery performed at the same time
Must not meet any of the exclusion criteria
You will not qualify if you...
Known allergy to tranexamic acid (TXA)
Intracranial bleeding
Known defective color vision
History of venous or arterial thromboembolism
Active thromboembolic disease
Severe renal impairment (chronic kidney disease)
History of coagulation disorder
Known thrombocytopenia (platelets less than 150,000)
Current use of anticoagulant (blood thinner)
Uncontrolled diabetes mellitus preventing use of dexamethasone perioperatively
Cardiac arrhythmia
History of acute myocardial infarction, stroke, seizure, or liver failure
Laboratory results showing platelets less than 150,000, prothrombin time over 45, INR over 1.2, or seizure disorder
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Day of surgery
Participants undergo rhinoplasty surgery and receive either 1 gram IV tranexamic acid or placebo in the operating room just before surgical incision.
1 visit (in-person, surgery day)
Post-operative Follow-up
Duration - Up to 1 week following surgery
Participants are monitored for bleeding, swelling, and bruising after surgery.
Approximately 2 to 3 visits (in-person or remote) during the first week after surgery
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
5 Rs to Rescue Quality Improvement Program to Reduce Post-Surgery Deaths in Africa
A Multi-Center Trial Across Ethiopia, South Africa, Tanzania, and Uganda
Safety and Effectiveness of Indocyanine Green Imaging in Advanced Gastric Cancer Surgery Using 3D and Ultra High Resolution Laparoscopy
Using 68Ga-TCR-FAPI PETCT Imaging to Guide Surgery for Medullary Thyroid Cancer in Adults Aged 18 to 75
PINCER Platform Study for Solid Organ Cancers Providing Biosamples for Translational Research
Randomized Study Comparing Bariatric Surgery and Lifestyle Therapy for Severe NASH With Advanced Liver Fibrosis in Adults
Preventing Ovarian Cancer with Opportunistic Salpingectomy During Non-Gynecologic Surgery in Women 45 and Older
Using 3D Imaging Technology with Standard Scans to Guide Head and Neck Surgery
Evaluating Safety and Feasibility of Robotic Liver Surgery Compared to Other Liver Surgeries
Improving Surgical Recovery Programs for Adults with Low Health Literacy Using VISACT Strategy
Evaluating the S-PATH Clinical Decision Support System Compared to Usual Care
for Preoperative Blood Management in Surgery Patients
A Cluster-Randomized Crossover Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Comparison of the effects of remifentanil and dexmedetomidine on surgeon satisfaction with surgical field visualization and intraoperative bleeding during rhinoplasty.
Preoperative Tranexamic Acid for Treatment of Bleeding, Edema, and Ecchymosis in Patients Undergoing Rhinoplasty: A Systematic Review and Meta-analysis.
Sara Juliana de A de Vasconcellos, Edmundo M do Nascimento-Júnior, Marcel Vinícius de Aguiar Menezes...